Online program to enhance cognitive function in people with scleroderma
Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis
This study is testing an 8-week online program to see if it can help people with scleroderma improve their thinking skills and overall well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT06880627 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of an 8-week online educational program designed for individuals with systemic sclerosis, focusing on improving cognitive function and overall well-being. Participants will be divided into a Brain Boost group receiving the intervention and a waitlist control group. The study aims to measure improvements in cognitive abilities and self-management skills following the program. The hypothesis is that those in the intervention group will show significant enhancements compared to the control group by the end of the study period.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with systemic sclerosis who experience cognitive deficits and have access to the internet.
Not a fit: Patients with dementia, severe psychiatric disorders, or other neurological conditions may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance cognitive function and quality of life for patients with systemic sclerosis.
How similar studies have performed: While similar cognitive enhancement programs have shown promise in other populations, this specific approach for systemic sclerosis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have physician-diagnosis of Systemic sclerosis (SSc) (any subtype) * A score of ≥ 10 on the Perceived Deficits Questionnaire * A score of ≤ 7 on the 6-Item Cognitive Impairment Test * Have access to a reliable, internet-connected device (e.g. computer, smartphone, tablet) * Visual acuity with correction sufficient to work on a computer, smartphone, tablet or screen * Be able to read, speak, and understand English Exclusion Criteria: * Diagnosis of dementia or head injury * Other neurological disorders that might impact cognition * Have major psychiatric disorder such as major depression and schizophrenia * Complex, unstable health issues that would preclude full participation in the study (like a planned surgery or active cancer treatment)
Where this trial is running
Ann Arbor, Michigan
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
Study contacts
- Principal investigator: Yen Chen, PhD — University of Michigan
- Study coordinator: Elizabeth Haro, MPH
- Email: elharo@umich.edu
- Phone: 734-936-2123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.